Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Crossing Over01:34

Crossing Over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process called synapsis.
In order to...
Crossing over01:34

Crossing over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process called synapsis.
In order to...
Crossing Over01:30

Crossing Over

Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I, duplicated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Integrated Neurological Change Score Is a Sensitive Neurological Composite Measure to Evaluate Cervical Spinal Cord Injury Trials.

Journal of neurotrauma·2026
Same author

Multimodal investigation of neuropathic pain mechanisms in focal spinal lesions.

Scandinavian journal of pain·2026
Same author

Community-Based Exercise for Chronic Pain in People with Spinal Cord Injury: A Pragmatic Randomized Controlled Trial.

Archives of physical medicine and rehabilitation·2026
Same author

Perceptions of physical and occupational therapists on the utility of surface electromyography data in spinal cord injury rehabilitation.

PloS one·2026
Same author

Therapist perspectives on the clinical utility of hand performance information from at-home egocentric video in outpatient neurorehabilitation: a multi-methods evaluation study.

BMC medical informatics and decision making·2026
Same author

A Comparison of Biopsychosocial Features of Chronic Neuropathic Versus Musculoskeletal Pain in Adults with Spinal Cord Injury: Baseline Cross-Sectional Data from the EPIC-SCI Trial.

Topics in spinal cord injury rehabilitation·2026

Related Experiment Video

Updated: May 13, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

Traversing the translational trail for trials.

John D Steeves1, John L K Kramer, Jose Zariffa

  • 1ICORD (International Collaboration On Repair Discoveries), University of British Columbia and Vancouver Coastal Health, Blusson Spinal Cord Centre, Vancouver General Hospital , Vancouver, BC, Canada.

Topics in Spinal Cord Injury Rehabilitation
|March 6, 2013
PubMed
Summary

Designing clinical trials for neurological therapies, like spinal cord injury treatments, faces challenges. Key issues include trial protocols, patient selection, outcome measures, and statistical analysis to ensure effective rehabilitation strategies.

Keywords:
clinical trialsconfounding variableshuman study protocolsresponder analysisspinal cord injury

More Related Videos

Comparative Analysis of Lower Limb Kinematics between the Initial and Terminal Phase of 5km Treadmill Running
08:26

Comparative Analysis of Lower Limb Kinematics between the Initial and Terminal Phase of 5km Treadmill Running

Published on: July 17, 2020

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior
06:38

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

Published on: June 9, 2020

Related Experiment Videos

Last Updated: May 13, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

Comparative Analysis of Lower Limb Kinematics between the Initial and Terminal Phase of 5km Treadmill Running
08:26

Comparative Analysis of Lower Limb Kinematics between the Initial and Terminal Phase of 5km Treadmill Running

Published on: July 17, 2020

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior
06:38

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

Published on: June 9, 2020

Area of Science:

  • Neurology
  • Clinical Trials
  • Rehabilitation Medicine

Background:

  • Human studies of neurologically directed therapeutic interventions present significant challenges.
  • Spinal cord injury (SCI) clinical trial programs exemplify these difficulties.

Purpose of the Study:

  • To review the principles and challenges in designing clinical trial programs for neurologically directed therapeutic interventions.
  • To identify key considerations for effective SCI clinical trials.

Main Methods:

  • Review of different clinical trial protocols.
  • Analysis of inclusion/exclusion criteria for study subjects.
  • Evaluation of clinical endpoint selection and statistical approaches.

Main Results:

  • Identified numerous unresolved issues in SCI clinical trial design.
  • Highlighted potential confounding factors in data interpretation.
  • Emphasized the complexity of developing effective therapeutic prescriptions.

Conclusions:

  • Effective SCI treatments and rehabilitation strategies require addressing fundamental challenges in clinical trial design.
  • Further research is needed to refine methodologies for accurate data interpretation and reliable prescription of interventions.